{"id":"W4401436033","doi":"10.1093/bjd/ljae266.020","title":"639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Roflumilast; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Tolerability; Adverse effect; Vomiting; Clinical endpoint; Randomized controlled trial; Internal medicine; Dermatology Life Quality Index; Fluticasone propionate; Gastroenterology; Asthma; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001036951,0.000901162,0.002312789,0.0002747746,0.0003065819,0.0007014564,0.0005402043,0.001246004,0.006192051],"category_scores_gemma":[0.0007901452,0.0004308365,0.001530373,0.0002884744,0.0005012304,0.0005427462,0.0001916837,0.001617015,0.0008434621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005232709,"about_ca_system_score_gemma":0.001044503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008210619,"about_ca_topic_score_gemma":0.002209275,"domain_scores_codex":[0.9995664,0.0001941902,0.00004201948,0.00008481169,0.00005161495,0.0000609678],"domain_scores_gemma":[0.9995624,0.0001232969,0.0001162253,0.00002051253,0.00003371749,0.0001438301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9025728,0.0179313,0.003932307,0.002389947,0.001679187,0.0002835598,0.0001142426,0.000404395,0.01201276,0.000180105,0.002145772,0.05635363],"study_design_scores_gemma":[0.8512591,0.1385198,0.006868316,0.0001025822,0.0006947372,0.0001413701,0.00003040606,0.0003762559,0.0007037076,0.00005943114,0.001231607,0.00001265269],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818383,0.01169466,0.0004121419,0.0004038617,0.0002537678,0.002303369,0.0009278802,0.0001062532,0.002059736],"genre_scores_gemma":[0.9880587,0.004860926,0.001087998,0.0008709235,0.0002702231,0.002706986,0.0008040405,0.00001848923,0.001321623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006192051,"threshold_uncertainty_score":0.02071452,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00699859495050022,"score_gpt":0.2653204882726066,"score_spread":0.2583218933221064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}